Mouse preimplantation embryo responses to culture medium osmolarity include increased expression of CCM2 and p38 MAPK activation.

Publisher: BioMed Central Country of Publication: England NLM ID: 100966973 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-213X (Electronic) Linking ISSN: 1471213X NLM ISO Abbreviation: BMC Dev Biol Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-2021]

Blastocyst/*metabolism ; Microfilament Proteins/*biosynthesis ; p38 Mitogen-Activated Protein Kinases/*metabolism; Animals ; Blastocyst/cytology ; Cells, Cultured ; Culture Media ; Enzyme Activation ; Female ; Fluorescent Antibody Technique, Indirect ; Gene Expression ; Mice ; Microfilament Proteins/genetics ; Microscopy, Confocal ; Osmolar Concentration ; Phosphorylation ; Pregnancy ; Reverse Transcriptase Polymerase Chain Reaction ; p38 Mitogen-Activated Protein Kinases/genetics

Background: Mechanisms that confer an ability to respond positively to environmental osmolarity are fundamental to ensuring embryo survival during the preimplantation period. Activation of p38 mitogen-activated protein kinase (MAPK) occurs following exposure to hyperosmotic treatment. Recently, a novel scaffolding protein called Osmosensing Scaffold for MEKK3 (OSM) was linked to p38 MAPK activation in response to sorbitol-induced hypertonicity. The human ortholog of OSM is cerebral cavernous malformation 2 (CCM2). The present study was conducted to investigate whether CCM2 is expressed during mouse preimplantation development and to determine whether this scaffolding protein is associated with p38 MAPK activation following exposure of preimplantation embryos to hyperosmotic environments.
Results: Our results indicate that Ccm2 along with upstream p38 MAPK pathway constituents (Map3k3, Map2k3, Map2k6, and Map2k4) are expressed throughout mouse preimplantation development. CCM2, MAP3K3 and the phosphorylated forms of MAP2K3/MAP2K6 and MAP2K4 were also detected throughout preimplantation development. Embryo culture in hyperosmotic media increased p38 MAPK activity in conjunction with elevated CCM2 levels.
Conclusion: These results define the expression of upstream activators of p38 MAPK during preimplantation development and indicate that embryo responses to hyperosmotic environments include elevation of CCM2 and activation of p38 MAPK.

FEBS Lett. 2003 Mar 27;539(1-3):29-33. (PMID: 12650921)
Dev Biol. 2003 Apr 15;256(2):342-54. (PMID: 12679107)
J Biol Chem. 2003 May 2;278(18):15765-70. (PMID: 12600999)
J Gen Physiol. 2003 Jul;122(1):5-16. (PMID: 12810851)
Mech Dev. 2002 Dec;119 Suppl 1:S21-6. (PMID: 14516655)
J Biol Chem. 2003 Nov 7;278(45):44525-34. (PMID: 12944406)
Nat Cell Biol. 2003 Dec;5(12):1104-10. (PMID: 14634666)
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13982-7. (PMID: 14615585)
Dev Biol. 2004 Apr 1;268(1):76-88. (PMID: 15031106)
In Vitro. 1980 Aug;16(8):669-74. (PMID: 7419236)
J Exp Zool. 1990 Feb;253(2):215-9. (PMID: 2313249)
EMBO J. 1992 Nov;11(11):3985-94. (PMID: 1327754)
Mol Reprod Dev. 1993 Apr;34(4):380-90. (PMID: 8471260)
Science. 1994 Aug 5;265(5173):808-11. (PMID: 7914033)
Nature. 1994 Dec 22-29;372(6508):739-46. (PMID: 7997261)
Science. 1995 Feb 3;267(5198):682-5. (PMID: 7839144)
Mol Reprod Dev. 1995 Jun;41(2):232-8. (PMID: 7654376)
EMBO J. 1995 Dec 1;14(23):5957-64. (PMID: 8846788)
J Biol Chem. 1996 Feb 9;271(6):2886-91. (PMID: 8621675)
J Biol Chem. 1996 Jul 26;271(30):17920-6. (PMID: 8663524)
FEBS Lett. 1996 Oct 21;395(2-3):133-6. (PMID: 8898080)
Biochem Biophys Res Commun. 1996 Nov 12;228(2):334-40. (PMID: 8920915)
Biol Reprod. 1997 Jun;56(6):1550-8. (PMID: 9166709)
EMBO J. 1997 Jun 16;16(12):3563-71. (PMID: 9218798)
J Biol Chem. 1997 Nov 28;272(48):30122-8. (PMID: 9374491)
J Biol Chem. 1998 Jan 16;273(3):1832-7. (PMID: 9430735)
J Pharmacol Exp Ther. 1998 Feb;284(2):687-92. (PMID: 9454815)
EMBO J. 1998 Jun 15;17(12):3372-84. (PMID: 9628874)
Am J Physiol. 1998 Oct;275(4 Pt 2):F478-86. (PMID: 9755119)
Physiol Rev. 1999 Jan;79(1):143-80. (PMID: 9922370)
Am J Physiol Renal Physiol. 2004 Dec;287(6):F1102-10. (PMID: 15522988)
Development. 2005 Apr;132(8):1773-83. (PMID: 15772134)
J Cell Physiol. 2005 Jul;204(1):273-9. (PMID: 15672418)
Mol Reprod Dev. 2005 Aug;71(4):422-30. (PMID: 15892044)
Biol Cell. 2005 Aug;97(8):629-40. (PMID: 15850458)
Mol Reprod Dev. 2005 Oct;72(2):152-60. (PMID: 16013066)
Hum Mol Genet. 2005 Sep 1;14(17):2521-31. (PMID: 16037064)
Dev Biol. 2006 Jan 15;289(2):406-19. (PMID: 16356488)
Biol Reprod. 2006 Apr;74(4):625-32. (PMID: 16339044)
Physiol Rev. 2001 Apr;81(2):807-69. (PMID: 11274345)
Anal Quant Cytol Histol. 2006 Feb;28(1):43-53. (PMID: 16566279)
J Neurosci. 2000 Oct 15;20(20):7602-13. (PMID: 11027220)
Mol Reprod Dev. 2002 Jun;62(2):195-202. (PMID: 11984829)
Curr Top Dev Biol. 2001;52:55-106. (PMID: 11529430)
Biochim Biophys Acta. 2001 Dec 3;1522(2):82-8. (PMID: 11750058)

0 (Culture Media)
0 (Microfilament Proteins)
0 (osmosensing scaffold for MEKK3 protein, mouse)
EC 2.7.11.24 (p38 Mitogen-Activated Protein Kinases)

Date Created: 20070112 Date Completed: 20070126 Latest Revision: 20181113

20221213

PMC1781062

10.1186/1471-213X-7-2

17214902